eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel
support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

close this panel
←Back
‹‹ Go Back

Wei Ma

University of Virginia



‹‹ Go Back

Feifang Hu

George Washington University



‹‹ Go Back

Lixin Zhang

Zhejiang University



546 – Recent Advances in Covariate-Adaptive Randomization in Clinical Trials: Statistical, Operational, and Regulatory Aspects

Statistical Inference Following Covariate-Adaptive Randomization: Recent Advances

Sponsor: Biopharmaceutical Section
Keywords: Covariate-adaptive randomization, Minimization, Conservative tests, Testing hypotheses, Stratification

Wei Ma

University of Virginia

Feifang Hu

George Washington University

Lixin Zhang

Zhejiang University

Covariate-adaptive randomization (CAR) has been increasingly implemented in clinical trials to balance important covariates. However, the properties of statistical inference following CAR are not fully understood. In the literature, most studies are based on simulations. In this paper, we summarize some recent advances on theoretical properties of hypothesis testing under CAR, proposed by Ma et al. (2014). We will first give a general review of basic concepts of CAR and motivations to study inference properties following CAR. We next summary the main results in the paper, including describing the framework and assumptions and giving the theoretical properties. In the linear model framework, asymptotical distributions of test statistics are given for testing treatment effects and significance of covariates under null and alternative hypotheses. In particular, it is shown that under a large class of CAR designs, (i) the hypothesis testing to compare treatment effects is usually conservative in terms of small Type I error; (ii) the hypothesis testing to compare treatment effects is usually more powerful than complete randomization; and (iii) the hypothesis testing for significance of covariates is still valid. We close with a discussion of related work and possible future directions.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2014 CadmiumCD